Global genotyping assay market expected to generate around USD 46.9 billion by 2025, at a CAGR of around 21.8% between 2019 and 2025. Genotyping is a technology used to identify genetic variation in the genomic sequence or allelic genes of an individual by comparing it against the reference sequence.
Genotyping Assay Market
The report covers a forecast and an analysis of the genotyping assay market on a global and regional level. The study provides historical data from 2016 to 2018 along with forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the genotyping assay market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the genotyping assay market on a global and regional level.
In order to give the users of this report a comprehensive view of the genotyping assay market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the genotyping assay market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, regional expansion of major participants involved in the genotyping assay market on a global and regional basis.
The study provides a decisive view of the genotyping assay market by segmenting it based on products and services, technology, application, end-user, and region. Based on products and services, the market is segmented into genotyping services, reagents and kits, instruments and bioinformatics. Instruments are further segmented into sequencers and amplifiers and analyzers. Bioinformatics segment includes software and services. By technology, the market is segmented into microarrays, polymerase chain reaction (PCR), sequencing, capillary electrophoresis, matrix-assisted laser desorption/ionization-time of flight (MALDI-Tof) mass spectrometry, and others. Polymerase chain reaction (PCR) is further segmented into real-time PCR and digital PCR. Sequencing segment is further split into next-generation sequencing, pyrosequencing, and Sanger sequencing. Capillary electrophoresis technology segment is further split into amplified fragment length polymorphism (AFLP), restriction fragment length polymorphism (RFLP), and single-strand conformation polymorphism. Based on application, the market is split into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. Pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others form the end-user segment of the market.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.
Some key players of the global genotyping assay market include Thermo Fisher Scientific, Inc., Illumina, Inc., Roche Diagnostics Limited, Danaher Corporation, Qiagen N.V., Fluidigm Corporation, Agilent Technologies, Inc., GE Healthcare, Integrated DNA Technologies, Inc., Genewiz, Inc., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Pacific Biosciences of California, Inc., and Eurofins Scientific.
This report segments the global genotyping assay market into:
Global Genotyping Assay Market: By Products and Services
Global Genotyping Assay Market: By Technology
Global Genotyping Assay Market: By Application
Global Genotyping Assay Market: By End-User
Global Genotyping Assay Market: By Region